InforMing the PAthway of COPD Treatment (The IMPACT Study): Single Inhaler Triple Therapy (Fluticasone Furoate/Umeclidinium/Vilanterol) Versus Fluticasone Furoate/Vilanterol and Umeclidinium/Vilanterol in Patients With COPD: An Analysis Based on Baseline COPD Medication Use
Research output: Contribution to journal › Conference abstract in journal › Research › peer-review
| Original language | English |
|---|---|
| Article number | A24 |
| Journal | American Journal of Respiratory and Critical Care Medicine |
| Volume | 199 |
| Issue number | A1116 |
| ISSN | 1073-449X |
| Publication status | Published - 2019 |
Links
- https://www.atsjournals.org/doi/pdf/10.1164/ajrccm-conference.2019.199.1_MeetingAbstracts.A1116
Final published version
ID: 218435775